323 related articles for article (PubMed ID: 1865969)
1. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
Rudnicki M; McNair P; Transbøl I; Nielsen B
Nephron; 1991; 58(2):144-9. PubMed ID: 1865969
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
4. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
5. Serum ionized calcium, as well as phosphorus and parathyroid hormone, is associated with the plasma 1,25-dihydroxyvitamin D3 concentration in normal postmenopausal women.
Dawson-Hughes B; Harris S; Dallal GE
J Bone Miner Res; 1991 May; 6(5):461-8. PubMed ID: 2068951
[TBL] [Abstract][Full Text] [Related]
6. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
[TBL] [Abstract][Full Text] [Related]
7. Normal plasma calcium, phosphate, and parathyroid hormone levels during 1,25(OH)2D3 infusions in rats.
Fox J; Kollenkirchen U
Am J Physiol; 1992 Jan; 262(1 Pt 1):E126-9. PubMed ID: 1733243
[TBL] [Abstract][Full Text] [Related]
8. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat.
Bushinsky DA; Riera GS; Favus MJ; Coe FL
J Clin Invest; 1985 Oct; 76(4):1599-604. PubMed ID: 3840495
[TBL] [Abstract][Full Text] [Related]
9. Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat.
Weisinger JR; Favus MJ; Langman CB; Bushinsky DA
J Bone Miner Res; 1989 Dec; 4(6):929-35. PubMed ID: 2610024
[TBL] [Abstract][Full Text] [Related]
10. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
Mortensen BM; Aarseth HP; Ganss R; Haug E; Gautvik KM; Gordeladze JO
Bone; 1993; 14(2):125-31. PubMed ID: 8334029
[TBL] [Abstract][Full Text] [Related]
11. Hypocalcemia, but not PTH or hypophosphatemia, induces a rapid increase in 1,25(OH)2D3 levels in rats.
Fox J
Am J Physiol; 1992 Feb; 262(2 Pt 1):E211-5. PubMed ID: 1539647
[TBL] [Abstract][Full Text] [Related]
12. High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease.
Yonemura K; Ohtake T; Matsushima H; Fujigaki Y; Hishida A
Clin Nephrol; 2004 Sep; 62(3):202-7. PubMed ID: 15481852
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
[TBL] [Abstract][Full Text] [Related]
15. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E
Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure.
Madsen S; Olgaard K; Ladefoged J
J Clin Endocrinol Metab; 1981 Oct; 53(4):823-7. PubMed ID: 6895227
[TBL] [Abstract][Full Text] [Related]
17. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
[TBL] [Abstract][Full Text] [Related]
19. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
Kates DM; Sherrard DJ; Andress DL
Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic metabolic alkalosis on Ca2+, PTH and 1,25(OH)2D3 in the rat.
Bushinsky DA; Kittaka MK; Weisinger JR; Langman CB; Favus MJ
Am J Physiol; 1989 Oct; 257(4 Pt 1):E578-82. PubMed ID: 2801937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
